COVID Vaccine Initiative

The COVID Vaccine Initiative (CVI) aims to ensure the development of safe, effective, and accessible vaccines for those most vulnerable to COVID-19: aging populations and those living in low- and middle-income countries. It leverages HVP’s global clinical research consortium, including newly established collaborations with the Harvard T.H. Chan School of Public Health focused on deciphering effective immunity in aging populations; FHI 360, a global nonprofit research and human development organization with extensive experience working in low and middle-income countries; and the University of Minnesota’s Center for Infectious Disease Research and Policy, a global leader in addressing public health preparedness and emerging infectious disease response.

COVID Newsroom

COVID Report

Feb 15, 2021

Issue 26: One Shot or Two?

Global COVID Lab Meeting

Feb 11, 2021

Christos Kyratsous, Ph.D.

Regeneron Pharmaceuticals

Global COVID Lab Meeting

Jan 28, 2021

Barney Graham, M.D., Ph.D.

National Institutes of Health

Global COVID Lab Meeting

Jan 14, 2021

Menno van Zelm, Ph.D.

Monash University